282 related articles for article (PubMed ID: 15308119)
1. CD4+CD25+ T regulatory cells inhibit cytotoxic activity of T CD8+ and NK lymphocytes in the direct cell-to-cell interaction.
Trzonkowski P; Szmit E; Myśliwska J; Dobyszuk A; Myśliwski A
Clin Immunol; 2004 Sep; 112(3):258-67. PubMed ID: 15308119
[TBL] [Abstract][Full Text] [Related]
2. CD4+CD25+ T regulatory cells inhibit cytotoxic activity of CTL and NK cells in humans-impact of immunosenescence.
Trzonkowski P; Szmit E; Myśliwska J; Myśliwski A
Clin Immunol; 2006 Jun; 119(3):307-16. PubMed ID: 16545982
[TBL] [Abstract][Full Text] [Related]
3. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
[TBL] [Abstract][Full Text] [Related]
4. Expansion of natural killer cell receptor (CD94/NKG2A)-expressing cytolytic CD8 T cells and CD4+CD25+ regulatory T cells from the same cord blood unit.
Tanaka J; Sugita J; Kato N; Toubai T; Ibata M; Shono Y; Ota S; Kondo T; Kobayashi T; Kobayashi M; Asaka M; Imamura M
Exp Hematol; 2007 Oct; 35(10):1562-6. PubMed ID: 17681668
[TBL] [Abstract][Full Text] [Related]
5. Human CD4+ CD25+ regulatory T cells suppress NKT cell functions.
Azuma T; Takahashi T; Kunisato A; Kitamura T; Hirai H
Cancer Res; 2003 Aug; 63(15):4516-20. PubMed ID: 12907625
[TBL] [Abstract][Full Text] [Related]
6. [Dendritic cells reduce the number and function of CD4+CD25+ cells in cytokine-induced killer cells].
Li H; Ren XB; Zhang P; An XM; Liu H; Hao XS
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(44):3134-8. PubMed ID: 16405818
[TBL] [Abstract][Full Text] [Related]
7. IL-2-independent generation of FOXP3(+)CD4(+)CD8(+)CD25(+) cytotoxic regulatory T cell lines from human umbilical cord blood.
Nakamura S; Suzuki M; Sugimoto A; Tsuji-Takayama K; Yamamoto M; Otani T; Inoue T; Harashima A; Okochi A; Motoda R; Yamasaki F; Orita K; Kibata M
Exp Hematol; 2007 Feb; 35(2):287-96. PubMed ID: 17258077
[TBL] [Abstract][Full Text] [Related]
8. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.
Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS
Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208
[TBL] [Abstract][Full Text] [Related]
9. In vivo elimination of CD25+ regulatory T cells leads to tumor rejection of B16F10 melanoma, when combined with interleukin-12 gene transfer.
Nagai H; Horikawa T; Hara I; Fukunaga A; Oniki S; Oka M; Nishigori C; Ichihashi M
Exp Dermatol; 2004 Oct; 13(10):613-20. PubMed ID: 15447721
[TBL] [Abstract][Full Text] [Related]
10. CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice.
Wolf D; Hochegger K; Wolf AM; Rumpold HF; Gastl G; Tilg H; Mayer G; Gunsilius E; Rosenkranz AR
J Am Soc Nephrol; 2005 May; 16(5):1360-70. PubMed ID: 15788479
[TBL] [Abstract][Full Text] [Related]
11. Transient activation of tumor-associated T-effector/memory cells promotes tumor eradication via NK-cell recruitment: minimal role for long-term T-cell immunity in cure of metastatic disease.
Gu T; Kilinc MO; Egilmez NK
Cancer Immunol Immunother; 2008 Jul; 57(7):997-1005. PubMed ID: 18049819
[TBL] [Abstract][Full Text] [Related]
12. CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer.
Kiniwa Y; Miyahara Y; Wang HY; Peng W; Peng G; Wheeler TM; Thompson TC; Old LJ; Wang RF
Clin Cancer Res; 2007 Dec; 13(23):6947-58. PubMed ID: 18056169
[TBL] [Abstract][Full Text] [Related]
13. Overlap between molecular markers expressed by naturally occurring CD4+CD25+ regulatory T cells and antigen specific CD4+CD25+ and CD8+CD28- T suppressor cells.
Scotto L; Naiyer AJ; Galluzzo S; Rossi P; Manavalan JS; Kim-Schulze S; Fang J; Favera RD; Cortesini R; Suciu-Foca N
Hum Immunol; 2004 Nov; 65(11):1297-306. PubMed ID: 15556680
[TBL] [Abstract][Full Text] [Related]
14. Abnormalities of peripheral blood T lymphocytes and natural killer cells in alcoholic hepatitis persist after a 3-month withdrawal period.
Laso FJ; Madruga JI; López A; Ciudad J; Alvarez-Mon M; San Miguel J; Orfao A
Alcohol Clin Exp Res; 1997 Jun; 21(4):672-6. PubMed ID: 9194923
[TBL] [Abstract][Full Text] [Related]
15. Human CD4+CD25+ regulatory cells have marked and sustained effects on CD8+ T cell activation.
Câmara NO; Sebille F; Lechler RI
Eur J Immunol; 2003 Dec; 33(12):3473-83. PubMed ID: 14635058
[TBL] [Abstract][Full Text] [Related]
16. Regulatory activity of human CD4 CD25 T cells depends on allergen concentration, type of allergen and atopy status of the donor.
Bellinghausen I; König B; Böttcher I; Knop J; Saloga J
Immunology; 2005 Sep; 116(1):103-11. PubMed ID: 16108822
[TBL] [Abstract][Full Text] [Related]
17. Role of new population of peripheral CD11c(+)CD8(+) T cells and CD4(+)CD25(+) regulatory T cells during acute and remission stages in rheumatoid arthritis patients.
Kao JK; Hsue YT; Lin CY
J Microbiol Immunol Infect; 2007 Oct; 40(5):419-27. PubMed ID: 17932602
[TBL] [Abstract][Full Text] [Related]
18. Early regulation of CD8 T cell alloreactivity by CD4+CD25- T cells in recipients of anti-CD154 antibody and allogeneic BMT is followed by rapid peripheral deletion of donor-reactive CD8+ T cells, precluding a role for sustained regulation.
Fehr T; Takeuchi Y; Kurtz J; Wekerle T; Sykes M
Eur J Immunol; 2005 Sep; 35(9):2679-90. PubMed ID: 16082727
[TBL] [Abstract][Full Text] [Related]
19. Novel mechanisms of suppressor activity exhibited by cytotoxic regulatory T cell lines, HOZOT.
Suzuki M; Sugimoto A; Harashima A; Otani T; Yamamoto M; Nakamura S; Yamasaki F; Nishiyama M; Okazaki Y; Kibata M
Exp Hematol; 2009 Jan; 37(1):92-100. PubMed ID: 19013006
[TBL] [Abstract][Full Text] [Related]
20. Generation of highly suppressive adaptive CD8(+)CD25(+)FOXP3(+) regulatory T cells by continuous antigen stimulation.
Mahic M; Henjum K; Yaqub S; Bjørnbeth BA; Torgersen KM; Taskén K; Aandahl EM
Eur J Immunol; 2008 Mar; 38(3):640-6. PubMed ID: 18266270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]